Published in Biochem Biophys Res Commun on March 25, 2008
Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth (2013) 2.70
Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2. J Lipid Res (2012) 1.28
Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation. Am J Pathol (2010) 1.01
Leucoreduction of blood components: an effective way to increase blood safety? Blood Transfus (2015) 0.94
Lipid alterations in experimental murine colitis: role of ceramide and imipramine for matrix metalloproteinase-1 expression. PLoS One (2009) 0.88
Prehypertension-associated elevation in circulating lysophosphatidlycholines, Lp-PLA2 activity, and oxidative stress. PLoS One (2014) 0.87
The ACTN3 R577X Polymorphism Is Associated with Cardiometabolic Fitness in Healthy Young Adults. PLoS One (2015) 0.84
Integrated metabolomics and metagenomics analysis of plasma and urine identified microbial metabolites associated with coronary heart disease. Sci Rep (2016) 0.84
Prevention of 1-palmitoyl lysophosphatidylcholine-induced inflammation by polyunsaturated acyl lysophosphatidylcholine. Inflamm Res (2012) 0.82
Metabolomics Investigation Reveals Metabolite Mediators Associated with Acute Lung Injury and Repair in a Murine Model of Influenza Pneumonia. Sci Rep (2016) 0.80
Mass spectrometry-based metabolite profiling in the mouse liver following exposure to ultraviolet B radiation. PLoS One (2014) 0.80
Lysophospholipids and their G protein-coupled receptors in atherosclerosis. Front Biosci (Landmark Ed) (2016) 0.78
Efficacy of Fluidized Bed Bioartificial Liver in Treating Fulminant Hepatic Failure in Pigs: A Metabolomics Study. Sci Rep (2016) 0.76
Choline Deficiency Causes Colonic Type II Natural Killer T (NKT) Cell Loss and Alleviates Murine Colitis under Type I NKT Cell Deficiency. PLoS One (2017) 0.75
Balance Between the Proinflammatory and Anti-Inflammatory Immune Responses with Blood Transfusion in Sepsis. Crit Care Nurs Clin North Am (2017) 0.75
SNARE proteins mediate fusion between cytosolic lipid droplets and are implicated in insulin sensitivity. Nat Cell Biol (2007) 3.69
Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol (2004) 2.41
Gene expression in autumn leaves. Plant Physiol (2003) 1.91
DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J Biol Chem (2004) 1.82
Expressed sequence tag-linked microsatellites as a source of gene-associated polymorphisms for detecting signatures of divergent selection in atlantic salmon (Salmo salar L.). Mol Biol Evol (2005) 1.77
Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice. J Am Coll Cardiol (2007) 1.77
Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide. J Lipid Res (2009) 1.70
Cytosolic lipid droplets increase in size by microtubule-dependent complex formation. Arterioscler Thromb Vasc Biol (2005) 1.62
Lipid droplets as dynamic organelles connecting storage and efflux of lipids. Biochim Biophys Acta (2008) 1.60
Inhibitory effect on arterial injury-induced neointimal formation by adoptive B-cell transfer in Rag-1 knockout mice. Arterioscler Thromb Vasc Biol (2002) 1.59
Short communication: Dating components of human atherosclerotic plaques. Circ Res (2010) 1.54
Retracted The SNARE protein SNAP23 and the SNARE-interacting protein Munc18c in human skeletal muscle are implicated in insulin resistance/type 2 diabetes. Diabetes (2010) 1.51
HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2003) 1.48
Elevated CD14++CD16- monocytes predict cardiovascular events. Circ Cardiovasc Genet (2012) 1.40
Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis. Arterioscler Thromb Vasc Biol (2010) 1.31
Association between diet, lifestyle, metabolic cardiovascular risk factors, and plasma C-reactive protein levels. Metabolism (2004) 1.26
Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro. J Hepatol (2012) 1.22
Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis. Circulation (2004) 1.19
Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences. Arterioscler Thromb Vasc Biol (2003) 1.19
Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation. Arterioscler Thromb Vasc Biol (2012) 1.17
Triglyceride containing lipid droplets and lipid droplet-associated proteins. Curr Opin Lipidol (2008) 1.16
Plasma fibronectin deficiency impedes atherosclerosis progression and fibrous cap formation. EMBO Mol Med (2012) 1.16
Vascular cellular adhesion molecule-1 (VCAM-1) expression in mice retinal vessels is affected by both hyperglycemia and hyperlipidemia. PLoS One (2010) 1.13
A phospholipase D-dependent process forms lipid droplets containing caveolin, adipocyte differentiation-related protein, and vimentin in a cell-free system. J Biol Chem (2003) 1.09
Nuclear factor of activated T cells regulates osteopontin expression in arterial smooth muscle in response to diabetes-induced hyperglycemia. Arterioscler Thromb Vasc Biol (2009) 1.08
Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease. Arterioscler Thromb Vasc Biol (2003) 1.08
Low levels of circulating CD4+FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for stroke. Arterioscler Thromb Vasc Biol (2012) 1.07
Regulatory T-cell response to apolipoprotein B100-derived peptides reduces the development and progression of atherosclerosis in mice. Arterioscler Thromb Vasc Biol (2012) 1.06
Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis - a review of the experimental evidence. Atherosclerosis (2012) 1.03
Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL. Atherosclerosis (2011) 1.03
CRP--marker or maker of cardiovascular disease? Arterioscler Thromb Vasc Biol (2005) 1.02
Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2005) 1.02
Analysis of protein interactions in situ by proximity ligation assays. Curr Top Microbiol Immunol (2014) 1.01
T cell modulation of intimal thickening after vascular injury: the bimodal role of IFN-gamma in immune deficiency. Arterioscler Thromb Vasc Biol (2005) 1.00
CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe⁻(/)⁻ mice. BMC Immunol (2010) 1.00
FcgammaRIIB inhibits the development of atherosclerosis in low-density lipoprotein receptor-deficient mice. J Immunol (2010) 1.00
T-helper 2 immunity is associated with reduced risk of myocardial infarction and stroke. Arterioscler Thromb Vasc Biol (2013) 0.98
High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction. Eur Heart J (2008) 0.98
Vaccination against atherosclerosis? Induction of atheroprotective immunity. Semin Immunopathol (2009) 0.97
Isolation and identification of thermophilic Campylobacter species in faecal samples from Swedish dogs. Scand J Infect Dis (2003) 0.97
Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression. Autoimmunity (2005) 0.97
Perilipin and adipophilin expression in lipid loaded macrophages. Biochem Biophys Res Commun (2007) 0.94
Detecting microRNA activity from gene expression data. BMC Bioinformatics (2010) 0.94
Autoantibody against the amino acid sequence 661-680 in apo B-100 is associated with decreased carotid stenosis and cardiovascular events. Atherosclerosis (2007) 0.94
Soluble urokinase plasminogen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque. Stroke (2012) 0.94
Interleukin-1beta and tumour necrosis factor-alpha impede neutral lipid turnover in macrophage-derived foam cells. BMC Immunol (2008) 0.94
Changes related to age and cerebrovascular symptoms in the extracellular matrix of human carotid plaques. Stroke (2003) 0.93
Development of a diet quality index assessing adherence to the Swedish nutrition recommendations and dietary guidelines in the Malmö Diet and Cancer cohort. Public Health Nutr (2011) 0.93
Generalized rank tests for replicated microarray data. Stat Appl Genet Mol Biol (2005) 0.92
The vascular repair process after injury of the carotid artery is regulated by IL-1RI and MyD88 signalling. Cardiovasc Res (2011) 0.92
Insulin-like growth factor II plays a central role in atherosclerosis in a mouse model. J Biol Chem (2001) 0.91
Association between IgM against an aldehyde-modified peptide in apolipoprotein B-100 and progression of carotid disease. Stroke (2007) 0.91
Cytokine response to lipoprotein lipid loading in human monocyte-derived macrophages. Lipids Health Dis (2006) 0.91
Lymphocytes in atherosclerosis. Clin Chim Acta (2012) 0.90
Plasma S100A8/A9 correlates with blood neutrophil counts, traditional risk factors, and cardiovascular disease in middle-aged healthy individuals. Arterioscler Thromb Vasc Biol (2013) 0.89
B regulatory cells are increased in hypercholesterolaemic mice and protect from lesion development via IL-10. Thromb Haemost (2015) 0.89
High disaccharide intake associates with atherogenic lipoprotein profile. Br J Nutr (2011) 0.89
The assembly of lipid droplets and its relation to cellular insulin sensitivity. Biochem Soc Trans (2009) 0.89
Inflammation and immunity in diabetic vascular complications. Curr Opin Lipidol (2008) 0.89
A high diet quality is associated with lower incidence of cardiovascular events in the Malmö diet and cancer cohort. PLoS One (2013) 0.89
Apolipoprotein B100 autoimmunity and atherosclerosis - disease mechanisms and therapeutic potential. Curr Opin Lipidol (2012) 0.89
Identification of a danger-associated peptide from apolipoprotein B100 (ApoBDS-1) that triggers innate proatherogenic responses. Circulation (2011) 0.88
Alternate trains of postural muscle vibration promote cyclic body displacement in standing parkinsonian patients. Mov Disord (2008) 0.87
Inhibition of injury-induced arterial remodelling and carotid atherosclerosis by recombinant human antibodies against aldehyde-modified apoB-100. Atherosclerosis (2006) 0.87
Atheroprotective effects of Alum are associated with capture of oxidized LDL antigens and activation of regulatory T cells. Circ Res (2009) 0.87
Shortened life span, bradycardia, and hypotension in mice with targeted expression of an Igf2 transgene in smooth muscle cells. Endocrinology (2003) 0.87
Very low-density lipoprotein induces interleukin-1beta expression in macrophages. Biochem Biophys Res Commun (2005) 0.86
Cystatin C and cathepsins in cardiovascular disease. Front Biosci (2008) 0.86
Treatment with beta-blockers is associated with lower levels of Lp-PLA2 and suPAR in carotid plaques. Cardiovasc Pathol (2013) 0.86
Will autoantibodies help to determine severity and progression of atherosclerosis? Curr Opin Lipidol (2004) 0.85
Simvastatin stimulates macrophage interleukin-1beta secretion through an isoprenylation-dependent mechanism. Vascul Pharmacol (2006) 0.85
TAP1-deficiency does not alter atherosclerosis development in Apoe-/- mice. PLoS One (2012) 0.85
Autoantibodies against modified low-density lipoproteins in coronary artery disease. Atherosclerosis (2003) 0.85
Inhibition of nuclear factor of activated T-cells (NFAT) suppresses accelerated atherosclerosis in diabetic mice. PLoS One (2013) 0.84
Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis. Cardiovasc Res (2011) 0.84
Involvement of the CD1d-natural killer T cell pathway in neointima formation after vascular injury. Circ Res (2007) 0.84
Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice. Atherosclerosis (2005) 0.84
Rip2 deficiency leads to increased atherosclerosis despite decreased inflammation. Circ Res (2011) 0.84
Laminin isoforms in atherosclerotic arteries from mice and man. Histol Histopathol (2011) 0.84
Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (-/-) mice. Biochem Biophys Res Commun (2005) 0.83
Linoleic acid-stimulated vascular adhesion molecule-1 expression in endothelial cells depends on nuclear factor-kappaB activation. Metabolism (2002) 0.83
Fibromodulin deficiency reduces low-density lipoprotein accumulation in atherosclerotic plaques in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol (2012) 0.83
Species identification by genotyping and determination of antibiotic resistance in Campylobacter jejuni and Campylobacter coli from humans and chickens in Sweden. Int J Food Microbiol (2004) 0.83